Clinical Trial

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Study acronym: IVUS in ESRD
Recruiting
View on ClinicalTrials.gov →
Summary
Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2020-05-21; most recent amendment 2025-11-26.
Status change: Not Yet Recruiting → Recruiting 2021-08-03
Trial Details
NCT Number NCT04399941
Lead Sponsor Boston Medical Center
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions End Stage Renal Disease
Enrollment 50 participants
Start Date 2021-08-03
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-01